Amneal Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone, and thank you for joining our session with Amneal. My name is Nathan Rich, and I follow the generic space here at Goldman Sachs. We're very pleased to welcome the management team from Amneal. We're joined by Chirag Patel, President and Co-CEO; and Tasos Konidaris, EVP and CFO. We also have Tony DiMeo from IR on the line. I think Chintu may join us as well, we'll have to see.
But before we jump in, I think everybody knows the drill at this point. I'd just like to remind the audience, though, if you do want to ask a question during the session, you can either e-mail me directly at [email protected] or you can submit the question through the Q&A function on the webcast.
Questions & Answers
So with that, I thought we might jump into the Q&A. Maybe starting at a high level, Chirag, in the nearly 2 years since you've come back to the company, how
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
